250 related articles for article (PubMed ID: 20571972)
1. Using NMR approaches to drive the search for new CNS therapeutics.
Borsook D; Becerra L
Curr Opin Investig Drugs; 2010 Jul; 11(7):771-8. PubMed ID: 20571972
[TBL] [Abstract][Full Text] [Related]
2. Removing obstacles in neuroscience drug discovery: the future path for animal models.
Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CNS disorders and evaluation of therapy using structural and functional MRI.
Rudin M; Mueggler T; Allegrini PR; Baumann D; Rausch M
Anal Bioanal Chem; 2003 Nov; 377(6):973-81. PubMed ID: 12942228
[TBL] [Abstract][Full Text] [Related]
4. Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration.
Brunner D; Balcı F; Ludvig EA
Behav Processes; 2012 Feb; 89(2):187-95. PubMed ID: 22155361
[TBL] [Abstract][Full Text] [Related]
5. The role of imaging in proof of concept for CNS drug discovery and development.
Wong DF; Tauscher J; Gründer G
Neuropsychopharmacology; 2009 Jan; 34(1):187-203. PubMed ID: 18843264
[TBL] [Abstract][Full Text] [Related]
6. Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery.
Nathan PJ; Phan KL; Harmer CJ; Mehta MA; Bullmore ET
Curr Opin Pharmacol; 2014 Feb; 14():54-61. PubMed ID: 24565013
[TBL] [Abstract][Full Text] [Related]
7. A role for fMRI in optimizing CNS drug development.
Borsook D; Becerra L; Hargreaves R
Nat Rev Drug Discov; 2006 May; 5(5):411-24. PubMed ID: 16604100
[TBL] [Abstract][Full Text] [Related]
8. Predictive in vivo animal models and translation to clinical trials.
Cook N; Jodrell DI; Tuveson DA
Drug Discov Today; 2012 Mar; 17(5-6):253-60. PubMed ID: 22493784
[TBL] [Abstract][Full Text] [Related]
9. Start small and stay small. Minimizing attrition in the clinic with a focus on CNS therapeutics.
Nienaber V
Curr Top Med Chem; 2009; 9(18):1688-704. PubMed ID: 19929834
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
[TBL] [Abstract][Full Text] [Related]
11. Prospects for the development of epigenetic drugs for CNS conditions.
Szyf M
Nat Rev Drug Discov; 2015 Jul; 14(7):461-74. PubMed ID: 26000723
[TBL] [Abstract][Full Text] [Related]
12. Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics.
Bifone A; Gozzi A
Expert Opin Drug Discov; 2012 Nov; 7(11):1071-82. PubMed ID: 22971143
[TBL] [Abstract][Full Text] [Related]
13. High-field MRS in clinical drug development.
Ross BD
Expert Opin Drug Discov; 2013 Jul; 8(7):849-63. PubMed ID: 23662912
[TBL] [Abstract][Full Text] [Related]
14. Use of functional imaging across clinical phases in CNS drug development.
Borsook D; Becerra L; Fava M
Transl Psychiatry; 2013 Jul; 3(7):e282. PubMed ID: 23860483
[TBL] [Abstract][Full Text] [Related]
15. CNS drug development - lost in translation?
Talevi A; Bellera CL; Di Ianni M; Gantner M; Bruno-Blanch LE; Castro EA
Mini Rev Med Chem; 2012 Sep; 12(10):959-70. PubMed ID: 22420574
[TBL] [Abstract][Full Text] [Related]
16. Translational research in central nervous system drug discovery.
Hurko O; Ryan JL
NeuroRx; 2005 Oct; 2(4):671-82. PubMed ID: 16489374
[TBL] [Abstract][Full Text] [Related]
17. Tools in the Design of Therapeutic Drugs for CNS Disorders: An up-to-date Review.
Sahu JK; Mishra AK
Curr Mol Pharmacol; 2018; 11(4):270-278. PubMed ID: 30129422
[TBL] [Abstract][Full Text] [Related]
18.
Moreno MJ; Ling B; Stanimirovic DB
Expert Opin Drug Discov; 2020 Aug; 15(8):903-915. PubMed ID: 32396023
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the discovery and development of negative allosteric modulators of mGluR5.
Lindsley CW; Emmitte KA
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):446-57. PubMed ID: 19562641
[TBL] [Abstract][Full Text] [Related]
20. Using Xenopus oocytes in neurological disease drug discovery.
Zeng SL; Sudlow LC; Berezin MY
Expert Opin Drug Discov; 2020 Jan; 15(1):39-52. PubMed ID: 31674217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
